Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.41 |
| ▸ | NMBR | P28336 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.35 |
| ▸ | CCKBR | P32239 | 3/20 | 0.35 |
| ▸ | CCKAR | P32238 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30882170 | 0.92 | SIRT2 (0.43) | SIRT2NMBRPTPN1 | |
| SCHEMBL30277394 | 0.90 | NMBR (0.44) | SIRT2NMBR | |
| SCHEMBL30665993 | 0.83 | NMBR (0.44) | SIRT2NMBR | |
| SCHEMBL30107538 | 0.82 | SIRT2 (0.44) | SIRT2NMBR | |
| SCHEMBL30107533 | 0.81 | REN (0.41) | SIRT2NMBR | |
| SCHEMBL29549611 | 0.81 | SIRT2 (0.37) | SIRT2NMBR | |
| SCHEMBL30250367 | 0.81 | NMBR (0.42) | SIRT2NMBR | |
| SCHEMBL30129799 | 0.79 | SIRT2 (0.46) | SIRT2NMBR | |
| SCHEMBL29427178 | 0.79 | NMBR (0.51) | SIRT2NMBR | |
| SCHEMBL29427176 | 0.79 | NMBR (0.51) | SIRT2NMBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662222-A1 | PROCESS FOR THE PREPARATION OF TETRAPEPTIDE FRAGMENT OF LIRAGLUTIDE | Fresenius Kabi Oncology Ltd (IN) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166022-A1 | PROCESS FOR THE PREPARATION OF TETRAPEPTIDE FRAGMENT OF LIRAGLUTIDE | FRESENIUS KABI ONCOLOGY LTD (IN) | 2024-08-15 | — | — | WO | disclosed |